Zura Bio (ZURA) News Today $1.47 0.00 (0.00%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$1.46 0.00 (-0.34%) As of 09:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Boxer Capital Management LLC Makes New Investment in Zura Bio Limited (NASDAQ:ZURA)Boxer Capital Management LLC bought a new stake in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 300,000 shares of the company's stock, valued at aMay 4 at 6:25 AM | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives $14.67 Consensus PT from BrokeragesMay 4 at 1:57 AM | americanbankingnews.comZura Bio (ZURA) Projected to Post Quarterly Earnings on ThursdayZura Bio (NASDAQ:ZURA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-zura-bio-limited-stock/)May 3 at 5:31 AM | marketbeat.comAdage Capital Partners GP L.L.C. Buys Shares of 300,000 Zura Bio Limited (NASDAQ:ZURA)Adage Capital Partners GP L.L.C. purchased a new position in Zura Bio Limited (NASDAQ:ZURA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 300,000 shares of the company's stock, valued aMay 2 at 4:46 AM | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Average Recommendation of "Buy" from AnalystsZura Bio Limited (NASDAQ:ZURA - Get Free Report) has received an average rating of "Buy" from the eight brokerages that are covering the stock, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the cMay 1, 2025 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Short Interest Down 51.8% in AprilZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 2,590,000 shares, a decline of 51.8% from the March 31st total of 5,370,000 shares. Based on an average daily volume of 373,200 shares, the short-interest ratio is presently 6.9 days. Approximately 5.6% of the company's shares are sold short.April 30, 2025 | marketbeat.comAfter losing 56% in the past year, Zura Bio Limited (NASDAQ:ZURA) institutional owners must be relieved by the recent gainApril 24, 2025 | finance.yahoo.comJPMorgan Chase & Co. Raises Stock Holdings in Zura Bio Limited (NASDAQ:ZURA)JPMorgan Chase & Co. boosted its stake in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) by 12,060.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,633,185 shares of the company's stock aftApril 20, 2025 | marketbeat.comADAR1 Capital Management LLC Cuts Stake in Zura Bio Limited (NASDAQ:ZURA)ADAR1 Capital Management LLC decreased its stake in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 44.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,077,251 shares of the company's stock after selling 1,693,39April 9, 2025 | marketbeat.comHC Wainwright Has Negative Estimate for Zura Bio Q1 EarningsZura Bio Limited (NASDAQ:ZURA - Free Report) - Investment analysts at HC Wainwright lowered their Q1 2025 earnings per share estimates for shares of Zura Bio in a note issued to investors on Thursday, April 3rd. HC Wainwright analyst M. Kapoor now forecasts that the company will earn ($0.21) perApril 8, 2025 | marketbeat.comHC Wainwright Cuts Zura Bio (NASDAQ:ZURA) Price Target to $3.00HC Wainwright cut their target price on Zura Bio from $5.00 to $3.00 and set a "neutral" rating on the stock in a research report on Thursday.April 5, 2025 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Average Recommendation of "Buy" from BrokeragesZura Bio Limited (NASDAQ:ZURA - Get Free Report) has been given an average rating of "Buy" by the eight analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a stronApril 5, 2025 | marketbeat.comZura Bio price target lowered to $3 from $5 at H.C. WainwrightApril 4, 2025 | markets.businessinsider.comZura Bio (ZURA) Gets a Buy from GuggenheimMarch 31, 2025 | markets.businessinsider.comAnalysts Set Expectations for Zura Bio FY2025 EarningsZura Bio Limited (NASDAQ:ZURA - Free Report) - Equities research analysts at Cantor Fitzgerald dropped their FY2025 earnings estimates for shares of Zura Bio in a report issued on Wednesday, March 26th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will post earnings of ($0March 29, 2025 | marketbeat.comQ1 Earnings Forecast for Zura Bio Issued By Leerink PartnrsZura Bio Limited (NASDAQ:ZURA - Free Report) - Leerink Partnrs increased their Q1 2025 earnings per share estimates for Zura Bio in a research report issued to clients and investors on Tuesday, March 25th. Leerink Partnrs analyst F. Khurshid now anticipates that the company will post earnings ofMarch 29, 2025 | marketbeat.comZura Bio (NASDAQ:ZURA) Releases Quarterly Earnings ResultsZura Bio (NASDAQ:ZURA - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.09. The company had revenue of $0.00 million during the quarter.March 28, 2025 | marketbeat.comZura Bio's (ZURA) Buy Rating Reaffirmed at GuggenheimGuggenheim reiterated a "buy" rating and set a $15.00 price objective on shares of Zura Bio in a report on Wednesday.March 27, 2025 | marketbeat.comZura Bio (NASDAQ:ZURA) Price Target Cut to $10.00 by Analysts at Chardan CapitalChardan Capital lowered their target price on Zura Bio from $12.00 to $10.00 and set a "buy" rating for the company in a report on Wednesday.March 27, 2025 | marketbeat.comHopeful Week For Insiders Who Bought US$1.01m Of Zura Bio StockMarch 26, 2025 | finance.yahoo.comZura Bio Limited: 2024 Financial Results and Strategic ProgressMarch 26, 2025 | tipranks.comZura Bio Reports Full Year 2024 Financial Results and Recent Corporate UpdatesMarch 25, 2025 | businesswire.comZura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of "Buy" by BrokeragesShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have received a consensus rating of "Buy" from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating andMarch 10, 2025 | marketbeat.comZura Bio (NASDAQ:ZURA) Trading Down 1.6% - Here's WhyZura Bio (NASDAQ:ZURA) Trading Down 1.6% - Should You Sell?March 8, 2025 | marketbeat.comZura Bio to Present at the Leerink Partners Global Healthcare ConferenceFebruary 24, 2025 | businesswire.comZURA stock touches 52-week low at $1.44 amid market shiftsFebruary 11, 2025 | msn.comCantor Fitzgerald Forecasts Zura Bio FY2025 EarningsZura Bio Limited (NASDAQ:ZURA - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Zura Bio in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings per shareJanuary 23, 2025 | marketbeat.comWe Think Zura Bio (NASDAQ:ZURA) Can Afford To Drive Business GrowthJanuary 22, 2025 | finance.yahoo.comZura Bio Limited (NASDAQ:ZURA) Given Consensus Recommendation of "Buy" by BrokeragesShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have been given a consensus rating of "Buy" by the seven brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and oneJanuary 19, 2025 | marketbeat.comZura Bio Highlights Strategic Goals and Clinical AdvancesJanuary 13, 2025 | tipranks.comGeode Capital Management LLC Acquires 377,545 Shares of Zura Bio Limited (NASDAQ:ZURA)Geode Capital Management LLC boosted its holdings in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 70.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 912,625 shares of the company's stock after buyingJanuary 7, 2025 | marketbeat.comZura Bio initiates Phase II systemic sclerosis treatment trialDecember 25, 2024 | msn.comZura Bio (NASDAQ:ZURA) Receives Neutral Rating from HC WainwrightHC Wainwright restated a "neutral" rating and set a $5.00 price objective on shares of Zura Bio in a report on Tuesday.December 24, 2024 | marketbeat.comLeerink Partnrs Forecasts Stronger Earnings for Zura BioZura Bio Limited (NASDAQ:ZURA - Free Report) - Equities researchers at Leerink Partnrs lifted their FY2025 earnings per share (EPS) estimates for shares of Zura Bio in a research note issued on Wednesday, December 11th. Leerink Partnrs analyst F. Khurshid now anticipates that the company will posDecember 13, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Average Rating of "Buy" from BrokeragesShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have been given an average recommendation of "Buy" by the seven analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendationNovember 30, 2024 | marketbeat.comBraidwell LP Buys New Position in Zura Bio Limited (NASDAQ:ZURA)Braidwell LP bought a new stake in Zura Bio Limited (NASDAQ:ZURA - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 2,472,806 shares of the company's stock, valued at approximately $10,040,000. Braidwell LP owned approximately 3.68% of Zura BioNovember 29, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Director Sells $2,734,458.09 in StockNovember 28, 2024 | insidertrades.comZura Bio Limited (NASDAQ:ZURA) Short Interest UpdateZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 4,960,000 shares, a growth of 183.4% from the October 31st total of 1,750,000 shares. Currently, 10.6% of the shares of the company are sold short. Based on an average trading volume of 444,500 shares, the short-interest ratio is currently 11.2 days.November 28, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) is Great Point Partners LLC's 10th Largest PositionGreat Point Partners LLC trimmed its position in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 29.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,263,672 shares of the company's stock after selling 1November 27, 2024 | marketbeat.comZura Bio to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 25, 2024 | businesswire.comHC Wainwright Reaffirms "Neutral" Rating for Zura Bio (NASDAQ:ZURA)HC Wainwright reissued a "neutral" rating and set a $5.00 target price on shares of Zura Bio in a report on Monday.November 18, 2024 | marketbeat.comZura Bio submits protocol to FDA for Phase 2 study of TibulizumabNovember 15, 2024 | markets.businessinsider.comZura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic SclerosisNovember 14, 2024 | businesswire.comQ3 Earnings Forecast for Zura Bio Issued By HC WainwrightZura Bio Limited (NASDAQ:ZURA - Free Report) - Research analysts at HC Wainwright raised their Q3 2025 earnings per share estimates for Zura Bio in a report released on Monday, November 11th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings of ($0.23) per shareNovember 13, 2024 | marketbeat.comZura Bio's (ZURA) Neutral Rating Reaffirmed at HC WainwrightHC Wainwright restated a "neutral" rating and set a $5.00 target price on shares of Zura Bio in a research note on Monday.November 11, 2024 | marketbeat.comChardan Capital Has Lowered Expectations for Zura Bio (NASDAQ:ZURA) Stock PriceChardan Capital reduced their price target on Zura Bio from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Friday.November 11, 2024 | marketbeat.comZura Bio Limited: Q3 2024 Financial Insights and Strategic ProgressNovember 8, 2024 | markets.businessinsider.comZura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 7, 2024 | businesswire.comQ3 Earnings Forecast for Zura Bio Issued By Leerink PartnrsZura Bio Limited (NASDAQ:ZURA - Free Report) - Analysts at Leerink Partnrs issued their Q3 2024 earnings per share estimates for shares of Zura Bio in a report released on Monday, November 4th. Leerink Partnrs analyst F. Khurshid anticipates that the company will earn ($0.14) per share for the quNovember 6, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Average Rating of "Moderate Buy" from BrokeragesZura Bio Limited (NASDAQ:ZURA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on theNovember 5, 2024 | marketbeat.com Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address ZURA Media Mentions By Week ZURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZURA News Sentiment▼0.920.73▲Average Medical News Sentiment ZURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZURA Articles This Week▼62▲ZURA Articles Average Week Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ORKA News KMDA News RVNC News TECX News TSHA News MAZE News ORIC News CMPS News TKNO News HRTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZURA) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZURA Stock Free ZURA Stock Alerts